Table: Aska Pharmaceutical Holdings -2023/24 div forecast
Nov 6 (Reuters) -
Aska Pharmaceutical Holdings Co., Ltd.
CONSOLIDATED EARNINGS ESTIMATES
(in billions of yen unless specified)
Full year to Full year to
Mar 31, 2024 Mar 31, 2024
LATEST PREVIOUS
FORECAST FORECAST
Annual Div 40.00 yen 20.00 yen
-Q2 Div 10.00 yen
-Q4 Div 20.00 yen 10.00 yen
NOTE - Aska Pharmaceutical Holdings Co., Ltd..
If there is no Q1 or Q3 dividend, Q2 will in most cases correspond to the first-half
dividend and Q4 to the second-half dividend announced before a new corporate law in 2006
allowed companies to pay and report dividends on a quarterly basis.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4886.T
Recent news on ASKA Pharmaceutical Holdings
See all newsTable: Aska Pharmaceutical Holdings -Q1 group results
Brief: Dalton Investment Strongly Oppose Conditional Activation Of Countermeasures Announced By Aska Pharmaceutical Holdings On May 25
Brief: Aska Pharmaceutical -Plan To Put To Shareholders Proposal On Countermeasures Against Potential Large-Scale Share Purchase By Dalton And Related Parties
Table: Aska Pharmaceutical Holdings -2025/26 group results
Table: Aska Pharmaceutical Holdings -2025/26 group results